bioRxivGeneticsPreprint
Deep mutational scanning of CYP2C19 reveals a substrate specificity-abundance tradeoff
Gabriel E. BoyleiD, Katherine A. SitkoiD, Jared GallowayiD, Hugh K. HaddoxiD, Aisha Haley BianchiiD, Ajeya DixoniD, Raine E. S. ThomsoniD, Riddhiman K. GargeiD, Allan E. RettieiD, Alan F. RubiniD, Renee C. GeckiD, Elizabeth M. J. GillamiD, William S. DeWittiD, Frederick A. Matsen IViD, Douglas M. FowleriD
Abstract
Cytochrome P450s (CYPs) are a family of enzymes responsible for metabolizing nearly 80% of small molecule drugs. Variants in CYPs can substantially alter drug metabolism, which may result in improper dosing and severe adverse drug reactions. CYPs have low sequence conservation, making it difficult to anticipate whether variant effects measured in one CYP may extend to others based on sequence alone. Even closely related CYPs, like CYP2C9 and its closest homolog CYP2C19, have distinct phenotypic properties despite sharing 92% amino acid sequence identity. Thus, we used Variant Abundance by Massively Parallel sequencing (VAMP-seq) to measure the steady-state protein abundance, a proxy for protein stability, of 7,660 missense variants in CYP2C19 expressed in cultured human cells. Our results confirmed positions and structural features critical for CYP function and revealed how variants at positions conserved across all eukaryotic CYPs influence abundance. We jointly analyzed 4,670 variants whose abundance was measured in both CYP2C19 and CYP2C9, finding that the homologs have different variant abundances in substrate recognition sites within the hydrophobic core, and that substitutions in some regions reduced abundance in CYP2C19 but not CYP2C9. We also measured the abundance of all single and some multiple WT amino acid exchanges between CYP2C19 and CYP2C9. While most exchanges had no effect, substitutions in substrate recognition site 4 (SRS4) reduced abundance in CYP2C19. When nearby amino acids were exchanged in double and triple mutants, we found distinct interactions between the sites in CYP2C19 and CYP2C9, revealing a region that is partially responsible for the difference in thermodynamic stability between the two homologs. Since these positions are also important for determining substrate specificity, there may be an evolutionary tradeoff between stability and altered enzymatic function. Finally, we used our data to analyze 368 previously unannotated human variants, finding that 43% had decreased abundance. Thus, by comparing variant effects between two closely related and important human genes, we have uncovered regions underlying their functional differences and paved the way for a more complete understanding of one of the most versatile families of enzymes.
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Massively parallel characterization of CYP2C9 variant enzyme activity and abundance
Clara J. Amorosi, Melissa A. Chiasson, … Maitreya J. Dunham·The American Journal of Human GeneticsPeer-reviewed·Jul 26, 2021
- Homology-Based Variant-Effect Predictors Break Down on Cytochrome P450 Pharmacogenes
Helen Z. Xu, Issah Samori, … Russ Biagio Altman·bioRxiv·Oct 2, 2026
- Genetic polymorphism of Cytochrome-P450-2C9 (CYP2C9) in Indian populations
Sheikh Nizamuddin, Shivendra Dubey, … K. Thangaraj·bioRxiv·Mar 5, 2017
- Variability in Human Drug Metabolizing Cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 Activities Caused by Genetic Variations in Cytochrome P450 Oxidoreductase
M. N. R. Velazques, S. Parween, … A. V. Pandey·bioRxiv·May 17, 2019
- Cross-validation of technologies for genotyping CYP2D6 and CYP2C19
Beatriz Carvalho Henriques, Amanda Buchner, … Katherine Jean Aitchison·Translational PsychiatryPeer-reviewed·Nov 22, 2021
- A novel pharmacogenetic testing panel for CYP2C19 genetic polymorphisms
Miracle Nmesomachi Enwere, Rachelle Turiello, … James P. Landers·bioRxiv·Feb 17, 2026